Type-2 diabetes mellitus enhances Klebsiella pneumoniae pathogenesis

Katlyn Todd,Krista Gunter,James M. Bowen,Caitlyn L. Holmes,Natasha L. Tilston-Lunel,Jay Vornhagen

DOI: https://doi.org/10.1101/2024.05.31.596766

2024-06-01

Abstract:Klebsiella pneumoniae is an opportunistic pathogen and an important cause of pneumonia, bacteremia, and urinary tract infection. K. pneumoniae infections are historically associated with diabetes mellitus. There is a fundamental gap in our understanding of how diabetes mellitus, specifically type 2 diabetes, influences K. pneumoniae pathogenesis. K. pneumoniae pathogenesis is a multifactorial process that often begins with gut colonization, followed by an escape from the gut to peripheral sites, leading to host damage and infection. We hypothesized that type 2 diabetes enhances K. pneumoniae pathogenesis. To test this, we used well-established mouse models of K. pneumoniae colonization and lung infection in conjunction with a mouse model of spontaneous type 2 diabetes mellitus (T2DM). We show that T2DM enhances susceptibility to both K. pneumoniae colonization and infection. The enhancement of gut colonization is dependent on T2DM-induced modulation of the gut microbiota community structure. In contrast, lung infection is exacerbated by the increased availability of amino acids in the lung, which is associated with higher levels of vascular endothelial growth factor. These data lay the foundation for mechanistic interrogation of the relationship between K. pneumoniae pathogenesis and type 2 diabetes mellitus, and explicitly establish T2DM as a risk factor for K. pneumoniae disease.

Microbiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is **how type 2 diabetes mellitus (T2DM) affects the pathogenicity of Klebsiella pneumoniae (Kp)**. Specifically, the researchers hypothesized that T2DM would enhance the pathogenicity of Kp and carried out a series of experiments to verify this hypothesis. They used a mouse model to explore the effects of T2DM on Kp lung infection and intestinal colonization, as well as the potential mechanisms behind these effects.

### Main research questions:
1. **Does T2DM increase the risk of Kp lung infection?**
- The researchers used a T2DM mouse model (db/db mice) and control group mice (db/+ and +/+ mice) and evaluated the effect of T2DM on Kp infection through a lung infection experiment.

2. **Does T2DM change the availability of lung metabolites, thereby affecting the infectivity of Kp?**
- By detecting the level of vascular endothelial growth factor (VEGF) in the lungs and the amino acid concentration in bronchoalveolar lavage fluid (BALF), the researchers explored the effect of T2DM on the lung metabolic environment.

3. **Does T2DM enhance the intestinal colonization ability of Kp by changing the structure of the gut microbiota?**
- Through an oral administration model and 16S rRNA gene sequencing, the researchers analyzed the effect of T2DM on the structure of the gut microbiota and its relationship with Kp intestinal colonization.

### Research background:
- **Type 2 diabetes mellitus (T2DM)**: Characterized by hyperglycemia, resulting from insulin resistance.
- **Klebsiella pneumoniae (Kp)**: It is a common opportunistic pathogen that can cause pneumonia, sepsis, and urinary tract infections.
- **T2DM and infection risk**: Previous studies have shown that patients with T2DM are more likely to develop infections, but the specific mechanisms are still unclear.

### Research objectives:
- **Verify the hypothesis**: T2DM does enhance the pathogenicity of Kp.
- **Reveal the mechanism**: Explore how T2DM affects the infectivity of Kp by changing the availability of lung metabolites and the structure of the gut microbiota.

Through these studies, the authors hope to provide new insights into understanding the relationship between T2DM and Kp infection and lay the foundation for further mechanism research.